A nurse is providing discharge instructions to a client who has asthma and is about to start taking theophylline (Theo-24). The nurse should tell the client that this medication might cause which of the following adverse effects?

The nurse should include the following information in the teaching about medication reconciliation:
● Provide a list of the client's current medications during admission to a healthcare facility.
● Provide a list of the client's current medications during the change of shift report.

Medication reconciliation is a critical process that involves comparing the medications a patient is currently taking with the medications ordered or intended to be prescribed. It helps ensure accurate and safe medication management during transitions of care. The nurse should emphasize the importance of providing a list of the client's current medications during admission to a healthcare facility. This information helps establish a baseline for the patient's medication regimen and allows healthcare providers to verify and reconcile the medications accurately.

Additionally, the nurse should instruct the class to provide a list of the client's current medications during the change of shift report. This allows for effective communication between healthcare providers, ensuring continuity of care and preventing medication errors or omissions.

While not specifically mentioned in the options, it is important to note that medication reconciliation should be performed at various points, including during the discharge process from a healthcare facility. Discharge medication reconciliation helps ensure a smooth transition to home or another healthcare setting, reduces the risk of medication-related issues, and promotes patient safety and adherence to the prescribed medication regimen.

Regarding over-the-counter medications, it is crucial to include them in the medication reconciliation process. Over-the-counter medications can interact with prescription medications and have potential side effects. Including them in the reconciliation report helps identify any potential interactions or duplications and ensures comprehensive medication management.

Leukotriene receptor antagonists (LTRAs) like Montelukast are commonly used in the treatment of asthma. They work by blocking the action of leukotrienes, which are inflammatory substances that can cause narrowing and inflammation of the airways in individuals with asthma. By preventing this inflammation, LTRAs help to reduce asthma symptoms and prevent asthma attacks.

The other options mentioned in the statements are not accurate or appropriate for teaching about Montelukast. Taking the medication only when experiencing symptoms is not the recommended approach, as LTRAs are typically taken regularly as part of ongoing asthma management. The statement about the therapeutic effect taking several weeks to notice is not accurate, as Montelukast can start to provide symptom relief within a shorter timeframe.

Additionally, the statement about increasing fiber and fluid intake to prevent constipation is unrelated to the use of Montelukast and may not apply to this medication specifically.